| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gene Expression Profiling | 46 | 2019 | 5159 | 3.270 |
Why?
|
| Gene Regulatory Networks | 20 | 2018 | 677 | 2.830 |
Why?
|
| Computational Biology | 18 | 2019 | 1271 | 2.620 |
Why?
|
| Transcription Factors | 35 | 2017 | 5270 | 2.330 |
Why?
|
| E2F4 Transcription Factor | 4 | 2017 | 30 | 2.210 |
Why?
|
| Transcriptome | 13 | 2018 | 1859 | 1.750 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 15 | 2011 | 2508 | 1.660 |
Why?
|
| Gene Expression Regulation, Neoplastic | 21 | 2020 | 8873 | 1.550 |
Why?
|
| Breast Neoplasms | 22 | 2019 | 15694 | 1.520 |
Why?
|
| Saccharomyces cerevisiae | 10 | 2018 | 621 | 1.440 |
Why?
|
| Molecular Sequence Annotation | 9 | 2017 | 201 | 1.430 |
Why?
|
| Chromatin Immunoprecipitation | 13 | 2017 | 518 | 1.380 |
Why?
|
| Genomics | 12 | 2020 | 2738 | 1.370 |
Why?
|
| Gene Expression Regulation | 20 | 2017 | 4053 | 1.360 |
Why?
|
| Gene Expression Regulation, Fungal | 8 | 2017 | 108 | 1.280 |
Why?
|
| Tumor Microenvironment | 8 | 2020 | 2864 | 1.200 |
Why?
|
| Gene Expression | 9 | 2018 | 3570 | 1.110 |
Why?
|
| Genome, Human | 13 | 2018 | 1869 | 1.080 |
Why?
|
| Algorithms | 21 | 2019 | 3890 | 1.070 |
Why?
|
| Hematopoiesis | 4 | 2016 | 560 | 1.050 |
Why?
|
| Caenorhabditis elegans | 9 | 2016 | 268 | 1.040 |
Why?
|
| DNA Methylation | 8 | 2019 | 2669 | 1.030 |
Why?
|
| RNA, Untranslated | 7 | 2014 | 237 | 0.990 |
Why?
|
| Chromatin | 11 | 2014 | 942 | 0.980 |
Why?
|
| Models, Genetic | 12 | 2016 | 1113 | 0.950 |
Why?
|
| Transcription, Genetic | 13 | 2017 | 3154 | 0.930 |
Why?
|
| CpG Islands | 7 | 2019 | 633 | 0.920 |
Why?
|
| MicroRNAs | 10 | 2016 | 2947 | 0.920 |
Why?
|
| STAT3 Transcription Factor | 3 | 2019 | 1121 | 0.890 |
Why?
|
| Histones | 8 | 2014 | 1466 | 0.890 |
Why?
|
| Sequence Analysis, RNA | 9 | 2019 | 651 | 0.850 |
Why?
|
| Data Mining | 2 | 2014 | 88 | 0.850 |
Why?
|
| Biomarkers, Tumor | 10 | 2020 | 10331 | 0.810 |
Why?
|
| Binding Sites | 15 | 2016 | 2171 | 0.770 |
Why?
|
| Databases, Genetic | 8 | 2017 | 745 | 0.760 |
Why?
|
| Databases, Nucleic Acid | 4 | 2018 | 117 | 0.740 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 5 | 2012 | 220 | 0.730 |
Why?
|
| Sequence Analysis, DNA | 11 | 2017 | 2483 | 0.710 |
Why?
|
| Galectin 3 | 3 | 2016 | 138 | 0.690 |
Why?
|
| Endometriosis | 3 | 2017 | 214 | 0.680 |
Why?
|
| Evolution, Molecular | 8 | 2016 | 834 | 0.660 |
Why?
|
| Saccharomyces cerevisiae Proteins | 7 | 2018 | 445 | 0.640 |
Why?
|
| Prognosis | 19 | 2020 | 21713 | 0.640 |
Why?
|
| B7 Antigens | 4 | 2020 | 84 | 0.630 |
Why?
|
| E2F1 Transcription Factor | 2 | 2016 | 206 | 0.630 |
Why?
|
| Cytogenetic Analysis | 1 | 2019 | 568 | 0.630 |
Why?
|
| Recombinational DNA Repair | 1 | 2017 | 79 | 0.600 |
Why?
|
| Genome | 3 | 2019 | 672 | 0.590 |
Why?
|
| Humans | 101 | 2020 | 261506 | 0.580 |
Why?
|
| Cell Cycle | 4 | 2013 | 2084 | 0.580 |
Why?
|
| Cell Cycle Checkpoints | 3 | 2018 | 278 | 0.560 |
Why?
|
| Leukocytes | 1 | 2018 | 422 | 0.560 |
Why?
|
| Caenorhabditis elegans Proteins | 2 | 2016 | 129 | 0.550 |
Why?
|
| Encyclopedias as Topic | 2 | 2012 | 7 | 0.550 |
Why?
|
| Genes, Neoplasm | 2 | 2017 | 324 | 0.540 |
Why?
|
| Adaptive Immunity | 1 | 2016 | 149 | 0.530 |
Why?
|
| Base Sequence | 18 | 2019 | 4917 | 0.530 |
Why?
|
| Receptors, Estrogen | 7 | 2019 | 2086 | 0.510 |
Why?
|
| Mycobacterium bovis | 1 | 2015 | 67 | 0.510 |
Why?
|
| User-Computer Interface | 1 | 2016 | 286 | 0.500 |
Why?
|
| Adaptation, Physiological | 1 | 2016 | 360 | 0.500 |
Why?
|
| Promoter Regions, Genetic | 10 | 2019 | 3101 | 0.490 |
Why?
|
| Genome, Fungal | 2 | 2011 | 54 | 0.490 |
Why?
|
| Survival Analysis | 11 | 2019 | 9180 | 0.480 |
Why?
|
| Infertility | 1 | 2016 | 123 | 0.480 |
Why?
|
| Macrophages | 2 | 2018 | 1304 | 0.480 |
Why?
|
| Models, Statistical | 5 | 2012 | 1171 | 0.480 |
Why?
|
| Computer Simulation | 4 | 2016 | 1529 | 0.480 |
Why?
|
| Cell Communication | 1 | 2017 | 509 | 0.470 |
Why?
|
| Liposarcoma | 1 | 2016 | 214 | 0.470 |
Why?
|
| Neuroblastoma | 1 | 2019 | 686 | 0.470 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2016 | 221 | 0.470 |
Why?
|
| Oxidative Stress | 4 | 2016 | 1129 | 0.470 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2018 | 406 | 0.470 |
Why?
|
| Epigenesis, Genetic | 3 | 2017 | 1399 | 0.450 |
Why?
|
| Conserved Sequence | 7 | 2014 | 469 | 0.450 |
Why?
|
| Animals | 41 | 2020 | 59536 | 0.440 |
Why?
|
| Estrogen Receptor alpha | 3 | 2015 | 701 | 0.440 |
Why?
|
| Adenocarcinoma | 4 | 2019 | 7789 | 0.430 |
Why?
|
| Software | 3 | 2016 | 1321 | 0.430 |
Why?
|
| Proportional Hazards Models | 6 | 2018 | 4988 | 0.420 |
Why?
|
| RNA Interference | 1 | 2016 | 1408 | 0.420 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2016 | 2291 | 0.410 |
Why?
|
| Neoplasms | 8 | 2020 | 15193 | 0.400 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2019 | 6915 | 0.400 |
Why?
|
| Amino Acid Motifs | 5 | 2015 | 392 | 0.400 |
Why?
|
| Homeostasis | 1 | 2016 | 950 | 0.390 |
Why?
|
| Disease Progression | 4 | 2019 | 6682 | 0.390 |
Why?
|
| Transcription Initiation Site | 5 | 2014 | 51 | 0.390 |
Why?
|
| Cell Line, Tumor | 14 | 2019 | 14551 | 0.390 |
Why?
|
| RNA, Messenger | 13 | 2016 | 6150 | 0.390 |
Why?
|
| Cell Proliferation | 11 | 2019 | 7226 | 0.390 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2017 | 3552 | 0.380 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 849 | 0.380 |
Why?
|
| Protein Binding | 9 | 2015 | 3438 | 0.370 |
Why?
|
| Intestinal Mucosa | 1 | 2016 | 1081 | 0.370 |
Why?
|
| 3' Untranslated Regions | 2 | 2019 | 343 | 0.360 |
Why?
|
| Internet | 4 | 2016 | 706 | 0.360 |
Why?
|
| DNA Copy Number Variations | 4 | 2020 | 1516 | 0.350 |
Why?
|
| Female | 40 | 2019 | 141928 | 0.350 |
Why?
|
| Cluster Analysis | 6 | 2015 | 1053 | 0.340 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 301 | 0.340 |
Why?
|
| Organ Specificity | 7 | 2016 | 699 | 0.330 |
Why?
|
| Signal Transduction | 13 | 2018 | 11965 | 0.330 |
Why?
|
| Leukemia | 2 | 2016 | 1635 | 0.330 |
Why?
|
| T-Lymphocytes | 3 | 2020 | 3869 | 0.320 |
Why?
|
| Cell Cycle Proteins | 2 | 2008 | 2045 | 0.320 |
Why?
|
| Skin Neoplasms | 3 | 2018 | 4654 | 0.310 |
Why?
|
| Phosphorylation | 2 | 2015 | 4804 | 0.300 |
Why?
|
| Progesterone | 3 | 2017 | 513 | 0.300 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2019 | 6207 | 0.300 |
Why?
|
| DNA | 2 | 2012 | 2693 | 0.300 |
Why?
|
| Antineoplastic Agents | 5 | 2019 | 14289 | 0.300 |
Why?
|
| Lung Neoplasms | 3 | 2018 | 11538 | 0.290 |
Why?
|
| Melanoma | 3 | 2018 | 5317 | 0.290 |
Why?
|
| DNA, Complementary | 6 | 2003 | 869 | 0.290 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2016 | 1763 | 0.290 |
Why?
|
| Fungal Proteins | 3 | 2017 | 254 | 0.280 |
Why?
|
| Endometrium | 3 | 2017 | 470 | 0.280 |
Why?
|
| Longevity | 1 | 2007 | 154 | 0.270 |
Why?
|
| HL-60 Cells | 2 | 2016 | 302 | 0.270 |
Why?
|
| Mice | 20 | 2020 | 34495 | 0.270 |
Why?
|
| Hypoxia | 2 | 2019 | 443 | 0.270 |
Why?
|
| Genome-Wide Association Study | 5 | 2018 | 2265 | 0.260 |
Why?
|
| Aspergillus fumigatus | 2 | 2017 | 135 | 0.260 |
Why?
|
| Molecular Sequence Data | 15 | 2013 | 6089 | 0.260 |
Why?
|
| Mutation | 8 | 2018 | 15179 | 0.260 |
Why?
|
| Survival Rate | 7 | 2020 | 12221 | 0.250 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2016 | 311 | 0.250 |
Why?
|
| BRCA1 Protein | 2 | 2019 | 493 | 0.250 |
Why?
|
| Biomarkers | 1 | 2016 | 5047 | 0.240 |
Why?
|
| Drosophila melanogaster | 4 | 2014 | 829 | 0.240 |
Why?
|
| Immunotherapy | 4 | 2020 | 3341 | 0.240 |
Why?
|
| RNA-Binding Proteins | 5 | 2017 | 984 | 0.230 |
Why?
|
| Genes, cdc | 2 | 2013 | 81 | 0.230 |
Why?
|
| Ribosomes | 3 | 2015 | 147 | 0.230 |
Why?
|
| Drug Discovery | 2 | 2016 | 324 | 0.230 |
Why?
|
| Models, Biological | 7 | 2018 | 3254 | 0.230 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2018 | 992 | 0.230 |
Why?
|
| Carcinoma | 1 | 2014 | 2578 | 0.220 |
Why?
|
| Glioblastoma | 3 | 2019 | 1797 | 0.220 |
Why?
|
| HeLa Cells | 4 | 2016 | 1643 | 0.220 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2015 | 2341 | 0.220 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 5437 | 0.210 |
Why?
|
| Membrane Proteins | 3 | 2020 | 2819 | 0.210 |
Why?
|
| Pancreatic Neoplasms | 1 | 2019 | 5061 | 0.210 |
Why?
|
| Nucleotide Motifs | 4 | 2017 | 62 | 0.210 |
Why?
|
| Yeasts | 2 | 2015 | 74 | 0.210 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 2 | 2014 | 197 | 0.210 |
Why?
|
| Artificial Intelligence | 3 | 2014 | 388 | 0.200 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 2 | 2017 | 40 | 0.190 |
Why?
|
| Cell Line | 6 | 2017 | 5114 | 0.190 |
Why?
|
| Genes, Fungal | 3 | 2014 | 84 | 0.190 |
Why?
|
| Peripheral Tolerance | 1 | 2020 | 4 | 0.190 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 10035 | 0.180 |
Why?
|
| Estradiol | 2 | 2016 | 748 | 0.180 |
Why?
|
| Neoplastic Stem Cells | 2 | 2019 | 1443 | 0.180 |
Why?
|
| Case-Control Studies | 5 | 2019 | 6100 | 0.180 |
Why?
|
| Estrogens | 2 | 2016 | 751 | 0.180 |
Why?
|
| Chromones | 2 | 2017 | 120 | 0.180 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2018 | 1586 | 0.180 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2019 | 376 | 0.180 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2019 | 5178 | 0.180 |
Why?
|
| Brain Neoplasms | 4 | 2018 | 4849 | 0.180 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2015 | 1242 | 0.180 |
Why?
|
| DNA-Binding Proteins | 4 | 2017 | 4821 | 0.180 |
Why?
|
| CD36 Antigens | 1 | 2019 | 53 | 0.180 |
Why?
|
| Neoadjuvant Therapy | 3 | 2017 | 4975 | 0.180 |
Why?
|
| Apoptosis | 9 | 2019 | 7591 | 0.180 |
Why?
|
| Schizosaccharomyces | 2 | 2018 | 116 | 0.180 |
Why?
|
| Support Vector Machine | 1 | 2019 | 44 | 0.170 |
Why?
|
| Cloning, Molecular | 9 | 2003 | 1213 | 0.170 |
Why?
|
| Morpholines | 2 | 2017 | 289 | 0.160 |
Why?
|
| Huntingtin Protein | 1 | 2018 | 60 | 0.160 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2018 | 101 | 0.160 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2019 | 100 | 0.160 |
Why?
|
| Mice, Inbred BALB C | 3 | 2019 | 2314 | 0.160 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2019 | 196 | 0.160 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 2018 | 84 | 0.160 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 233 | 0.160 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2018 | 2359 | 0.160 |
Why?
|
| Species Specificity | 4 | 2014 | 777 | 0.160 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2018 | 187 | 0.160 |
Why?
|
| Centromere Protein B | 1 | 2017 | 5 | 0.160 |
Why?
|
| Catabolite Repression | 1 | 2017 | 1 | 0.150 |
Why?
|
| MCF-7 Cells | 2 | 2016 | 550 | 0.150 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2018 | 157 | 0.150 |
Why?
|
| Lentivirus | 1 | 2018 | 169 | 0.150 |
Why?
|
| Epigenomics | 1 | 2019 | 266 | 0.150 |
Why?
|
| GATA1 Transcription Factor | 2 | 2014 | 16 | 0.150 |
Why?
|
| Exons | 5 | 2012 | 1328 | 0.150 |
Why?
|
| Lymphokines | 1 | 2018 | 272 | 0.150 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2017 | 467 | 0.150 |
Why?
|
| Wnt Signaling Pathway | 2 | 2017 | 430 | 0.150 |
Why?
|
| Protein Interaction Mapping | 3 | 2015 | 162 | 0.150 |
Why?
|
| Data Curation | 1 | 2017 | 11 | 0.150 |
Why?
|
| RNA Caps | 1 | 2016 | 34 | 0.150 |
Why?
|
| Sequence Alignment | 3 | 2008 | 844 | 0.150 |
Why?
|
| Genetic Pleiotropy | 1 | 2016 | 29 | 0.150 |
Why?
|
| Fatty Acids | 1 | 2019 | 448 | 0.140 |
Why?
|
| Receptor, Insulin | 1 | 2017 | 97 | 0.140 |
Why?
|
| Up-Regulation | 4 | 2018 | 2450 | 0.140 |
Why?
|
| Immune System | 1 | 2018 | 279 | 0.140 |
Why?
|
| Oncogene Proteins | 1 | 2018 | 354 | 0.140 |
Why?
|
| Neuropeptides | 1 | 2017 | 154 | 0.140 |
Why?
|
| Carbon | 1 | 2017 | 149 | 0.140 |
Why?
|
| Inhibitor of Differentiation Protein 2 | 1 | 2016 | 17 | 0.140 |
Why?
|
| Cation Transport Proteins | 2 | 2016 | 199 | 0.140 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2017 | 153 | 0.140 |
Why?
|
| Rad51 Recombinase | 1 | 2016 | 126 | 0.140 |
Why?
|
| Molecular Docking Simulation | 1 | 2016 | 144 | 0.140 |
Why?
|
| Computer-Aided Design | 1 | 2016 | 73 | 0.140 |
Why?
|
| Spheroids, Cellular | 1 | 2017 | 222 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2016 | 80 | 0.140 |
Why?
|
| Androstadienes | 1 | 2016 | 165 | 0.140 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2015 | 36 | 0.140 |
Why?
|
| Ubiquitin-Specific Proteases | 1 | 2016 | 73 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 476 | 0.130 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 470 | 0.130 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2020 | 1146 | 0.130 |
Why?
|
| Neurodegenerative Diseases | 1 | 2018 | 264 | 0.130 |
Why?
|
| Glioma | 2 | 2017 | 1963 | 0.130 |
Why?
|
| Genes, Regulator | 1 | 2015 | 69 | 0.130 |
Why?
|
| Methyltransferases | 1 | 2016 | 148 | 0.130 |
Why?
|
| Programming Languages | 1 | 2015 | 23 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 6 | 2019 | 5395 | 0.130 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 1217 | 0.130 |
Why?
|
| Neurospora crassa | 1 | 2014 | 6 | 0.130 |
Why?
|
| Logistic Models | 2 | 2015 | 3441 | 0.130 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 1 | 2014 | 9 | 0.130 |
Why?
|
| SEER Program | 1 | 2018 | 1000 | 0.130 |
Why?
|
| Aspergillosis | 1 | 2017 | 246 | 0.130 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2018 | 1678 | 0.130 |
Why?
|
| Terminator Regions, Genetic | 1 | 2014 | 8 | 0.130 |
Why?
|
| Cytoskeletal Proteins | 1 | 2017 | 492 | 0.130 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2017 | 347 | 0.130 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2016 | 503 | 0.130 |
Why?
|
| Transcriptional Activation | 2 | 2016 | 1070 | 0.120 |
Why?
|
| Small Molecule Libraries | 1 | 2016 | 169 | 0.120 |
Why?
|
| Disease-Free Survival | 2 | 2017 | 10001 | 0.120 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2016 | 316 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2013 | 4549 | 0.120 |
Why?
|
| Drug Design | 1 | 2016 | 375 | 0.120 |
Why?
|
| Circadian Clocks | 1 | 2014 | 66 | 0.120 |
Why?
|
| Phosphoproteins | 2 | 2017 | 1152 | 0.120 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2014 | 461 | 0.120 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2014 | 65 | 0.120 |
Why?
|
| ROC Curve | 1 | 2017 | 1183 | 0.120 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2017 | 1498 | 0.120 |
Why?
|
| Protein Biosynthesis | 2 | 2015 | 889 | 0.120 |
Why?
|
| E2F Transcription Factors | 1 | 2013 | 132 | 0.120 |
Why?
|
| Acetophenones | 1 | 2013 | 19 | 0.120 |
Why?
|
| Mitosis | 1 | 2016 | 615 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 1 | 2016 | 1165 | 0.120 |
Why?
|
| Tissue Distribution | 4 | 2002 | 875 | 0.120 |
Why?
|
| Genomic Instability | 1 | 2016 | 519 | 0.120 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2015 | 268 | 0.120 |
Why?
|
| Receptors, GABA-A | 1 | 2013 | 79 | 0.120 |
Why?
|
| RNA, Long Noncoding | 1 | 2019 | 598 | 0.110 |
Why?
|
| Area Under Curve | 1 | 2015 | 700 | 0.110 |
Why?
|
| Proteins | 2 | 2012 | 1963 | 0.110 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2016 | 726 | 0.110 |
Why?
|
| Germ-Line Mutation | 1 | 2018 | 1046 | 0.110 |
Why?
|
| Diploidy | 1 | 2013 | 114 | 0.110 |
Why?
|
| Genes, p53 | 1 | 2017 | 1090 | 0.110 |
Why?
|
| High-Throughput Screening Assays | 1 | 2014 | 216 | 0.110 |
Why?
|
| Blotting, Western | 2 | 2016 | 3536 | 0.110 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2014 | 160 | 0.110 |
Why?
|
| DNA Footprinting | 1 | 2012 | 34 | 0.110 |
Why?
|
| Deoxyribonuclease I | 1 | 2012 | 67 | 0.110 |
Why?
|
| Base Composition | 1 | 2012 | 92 | 0.110 |
Why?
|
| Time Factors | 6 | 2013 | 12926 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2016 | 5539 | 0.110 |
Why?
|
| beta Catenin | 1 | 2016 | 688 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 1493 | 0.110 |
Why?
|
| Sirolimus | 1 | 2016 | 814 | 0.110 |
Why?
|
| Cytokines | 2 | 2018 | 2809 | 0.110 |
Why?
|
| Mice, Nude | 2 | 2019 | 4307 | 0.110 |
Why?
|
| STAT4 Transcription Factor | 1 | 2011 | 10 | 0.100 |
Why?
|
| Stromal Cells | 1 | 2016 | 825 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2016 | 810 | 0.100 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 669 | 0.100 |
Why?
|
| K562 Cells | 3 | 2019 | 338 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2003 | 997 | 0.100 |
Why?
|
| Gene Components | 1 | 2011 | 16 | 0.100 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2018 | 1048 | 0.100 |
Why?
|
| Amino Acid Sequence | 9 | 2003 | 4233 | 0.100 |
Why?
|
| Breast | 2 | 2019 | 1344 | 0.100 |
Why?
|
| Chromosomes, Human | 1 | 2012 | 295 | 0.100 |
Why?
|
| Genome, Helminth | 1 | 2010 | 9 | 0.100 |
Why?
|
| Epithelial Cells | 2 | 2016 | 1818 | 0.100 |
Why?
|
| B7-H1 Antigen | 1 | 2018 | 1022 | 0.100 |
Why?
|
| Chorionic Gonadotropin | 1 | 2011 | 130 | 0.100 |
Why?
|
| Alcoholism | 1 | 2013 | 285 | 0.100 |
Why?
|
| Mammals | 1 | 2012 | 361 | 0.090 |
Why?
|
| Drosophila Proteins | 1 | 2017 | 858 | 0.090 |
Why?
|
| Genome, Insect | 1 | 2011 | 98 | 0.090 |
Why?
|
| Segmental Duplications, Genomic | 1 | 2010 | 83 | 0.090 |
Why?
|
| RNA | 1 | 2015 | 1013 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2002 | 179 | 0.090 |
Why?
|
| Acetylation | 1 | 2011 | 508 | 0.090 |
Why?
|
| Pseudogenes | 1 | 2010 | 81 | 0.090 |
Why?
|
| Systems Biology | 1 | 2010 | 112 | 0.090 |
Why?
|
| Trophoblasts | 1 | 2011 | 138 | 0.090 |
Why?
|
| DNA Repair | 2 | 2016 | 1872 | 0.090 |
Why?
|
| Structure-Activity Relationship | 2 | 2013 | 931 | 0.090 |
Why?
|
| Male | 12 | 2018 | 123000 | 0.090 |
Why?
|
| Chromosomes | 1 | 2010 | 244 | 0.090 |
Why?
|
| Databases, Factual | 1 | 2017 | 2218 | 0.090 |
Why?
|
| Receptor, ErbB-2 | 1 | 2019 | 2518 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 1546 | 0.090 |
Why?
|
| T-Cell Acute Lymphocytic Leukemia Protein 1 | 1 | 2009 | 9 | 0.090 |
Why?
|
| Protein Interaction Maps | 3 | 2016 | 149 | 0.090 |
Why?
|
| Quality Control | 1 | 2011 | 457 | 0.090 |
Why?
|
| Argonaute Proteins | 1 | 2009 | 40 | 0.090 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2009 | 65 | 0.090 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2019 | 1215 | 0.090 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2017 | 3890 | 0.090 |
Why?
|
| Ovarian Neoplasms | 2 | 2017 | 4638 | 0.090 |
Why?
|
| Lymphocyte Activation | 3 | 2020 | 1688 | 0.090 |
Why?
|
| Alleles | 2 | 2012 | 2437 | 0.090 |
Why?
|
| DNA, Neoplasm | 1 | 2015 | 1910 | 0.090 |
Why?
|
| Sarcomeres | 1 | 2009 | 42 | 0.090 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2009 | 92 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 2054 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 1130 | 0.090 |
Why?
|
| Transcription Factor AP-2 | 2 | 2015 | 79 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 778 | 0.080 |
Why?
|
| Proteomics | 1 | 2016 | 1380 | 0.080 |
Why?
|
| Ribonuclease III | 1 | 2009 | 182 | 0.080 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 591 | 0.080 |
Why?
|
| Escherichia coli | 1 | 2015 | 1203 | 0.080 |
Why?
|
| DNA Probes | 1 | 2008 | 217 | 0.080 |
Why?
|
| Free Radicals | 1 | 2007 | 62 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 2 | 2020 | 4367 | 0.080 |
Why?
|
| Histone Deacetylases | 2 | 2011 | 365 | 0.080 |
Why?
|
| Receptors, Steroid | 1 | 2009 | 286 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2330 | 0.080 |
Why?
|
| Cells, Cultured | 1 | 2016 | 5637 | 0.070 |
Why?
|
| Caloric Restriction | 1 | 2007 | 88 | 0.070 |
Why?
|
| Cytosol | 1 | 2007 | 238 | 0.070 |
Why?
|
| Mice, Inbred NOD | 2 | 2019 | 905 | 0.070 |
Why?
|
| Primary Cell Culture | 2 | 2017 | 208 | 0.070 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2018 | 265 | 0.070 |
Why?
|
| Neoplasm Metastasis | 2 | 2015 | 5112 | 0.070 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2007 | 234 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 1823 | 0.070 |
Why?
|
| Phenotype | 2 | 2018 | 6295 | 0.070 |
Why?
|
| Silent Information Regulator Proteins, Saccharomyces cerevisiae | 1 | 2005 | 9 | 0.070 |
Why?
|
| Zebrafish | 1 | 2009 | 463 | 0.070 |
Why?
|
| Pongo pygmaeus | 1 | 2005 | 6 | 0.070 |
Why?
|
| Neoplasm Proteins | 2 | 2017 | 3230 | 0.070 |
Why?
|
| Actins | 1 | 2009 | 608 | 0.070 |
Why?
|
| Reproducibility of Results | 4 | 2013 | 6009 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2018 | 32848 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 3343 | 0.070 |
Why?
|
| Oligonucleotide Probes | 1 | 2005 | 130 | 0.070 |
Why?
|
| Sirtuins | 1 | 2005 | 44 | 0.070 |
Why?
|
| Down-Regulation | 3 | 2019 | 2074 | 0.070 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2009 | 622 | 0.070 |
Why?
|
| Tacrolimus | 1 | 2006 | 335 | 0.060 |
Why?
|
| Brain | 3 | 2005 | 4113 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 3639 | 0.060 |
Why?
|
| Pan troglodytes | 1 | 2005 | 207 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2013 | 2488 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2012 | 2086 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 3578 | 0.060 |
Why?
|
| Chromosome Mapping | 3 | 2002 | 1471 | 0.060 |
Why?
|
| ras Proteins | 1 | 2007 | 770 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2005 | 482 | 0.060 |
Why?
|
| Testis | 3 | 2001 | 717 | 0.050 |
Why?
|
| Nucleic Acid Conformation | 2 | 2015 | 279 | 0.050 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2015 | 154 | 0.050 |
Why?
|
| Receptors, Angiotensin | 1 | 2002 | 44 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2002 | 1487 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2002 | 629 | 0.050 |
Why?
|
| Microtubule Proteins | 1 | 2001 | 41 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 1270 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 13658 | 0.050 |
Why?
|
| Hydroxysteroid Dehydrogenases | 1 | 2001 | 19 | 0.050 |
Why?
|
| United States | 1 | 2018 | 15433 | 0.050 |
Why?
|
| Cyclophilins | 1 | 2001 | 32 | 0.050 |
Why?
|
| Introns | 4 | 2003 | 432 | 0.050 |
Why?
|
| Stress, Physiological | 2 | 2017 | 492 | 0.050 |
Why?
|
| Hydrogen Peroxide | 2 | 2015 | 217 | 0.050 |
Why?
|
| Aged | 4 | 2019 | 70117 | 0.050 |
Why?
|
| Oxidoreductases | 1 | 2001 | 171 | 0.050 |
Why?
|
| Calcium | 1 | 2006 | 1537 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 7222 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2002 | 534 | 0.040 |
Why?
|
| Peptides | 3 | 2018 | 1479 | 0.040 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2003 | 661 | 0.040 |
Why?
|
| Reference Values | 2 | 2013 | 1099 | 0.040 |
Why?
|
| Cell Growth Processes | 1 | 2019 | 342 | 0.040 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2018 | 74 | 0.040 |
Why?
|
| Response Elements | 2 | 2009 | 193 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2019 | 181 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2018 | 37905 | 0.040 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2018 | 65 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 6942 | 0.040 |
Why?
|
| Homologous Recombination | 1 | 2019 | 185 | 0.040 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 181 | 0.040 |
Why?
|
| Microsatellite Instability | 1 | 2020 | 400 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2018 | 129 | 0.040 |
Why?
|
| Open Reading Frames | 2 | 2012 | 250 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2018 | 198 | 0.040 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2018 | 153 | 0.040 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2018 | 223 | 0.040 |
Why?
|
| Anemia | 1 | 2003 | 689 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2018 | 549 | 0.040 |
Why?
|
| Fetus | 1 | 2001 | 601 | 0.040 |
Why?
|
| Janus Kinase 1 | 1 | 2017 | 121 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2018 | 528 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2017 | 80 | 0.040 |
Why?
|
| Ovary | 1 | 2001 | 668 | 0.040 |
Why?
|
| Tyrphostins | 1 | 2017 | 107 | 0.040 |
Why?
|
| Heterografts | 1 | 2019 | 733 | 0.040 |
Why?
|
| Cell Movement | 2 | 2017 | 2466 | 0.040 |
Why?
|
| Adult | 4 | 2019 | 77950 | 0.040 |
Why?
|
| Primates | 1 | 2016 | 128 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2017 | 557 | 0.030 |
Why?
|
| Androgen Antagonists | 1 | 2018 | 411 | 0.030 |
Why?
|
| CDC2 Protein Kinase | 1 | 2016 | 176 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2018 | 576 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2019 | 9244 | 0.030 |
Why?
|
| Unsupervised Machine Learning | 1 | 2015 | 12 | 0.030 |
Why?
|
| Ligands | 1 | 2018 | 995 | 0.030 |
Why?
|
| Methylation | 1 | 2016 | 597 | 0.030 |
Why?
|
| Flavonoids | 1 | 2016 | 188 | 0.030 |
Why?
|
| Genes, myc | 1 | 2016 | 358 | 0.030 |
Why?
|
| Epithelium | 1 | 2017 | 720 | 0.030 |
Why?
|
| Knowledge Bases | 1 | 2015 | 41 | 0.030 |
Why?
|
| Pupa | 1 | 2014 | 22 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2016 | 342 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 673 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 1 | 2010 | 3976 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2015 | 88 | 0.030 |
Why?
|
| Estrogen Receptor beta | 1 | 2015 | 155 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 1742 | 0.030 |
Why?
|
| Telomerase | 1 | 2017 | 525 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2014 | 193 | 0.030 |
Why?
|
| Polycomb-Group Proteins | 1 | 2013 | 42 | 0.030 |
Why?
|
| Pyrazines | 1 | 2017 | 495 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 14889 | 0.030 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2015 | 217 | 0.030 |
Why?
|
| Larva | 1 | 2014 | 274 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2016 | 368 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2018 | 1869 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2014 | 89 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 1519 | 0.030 |
Why?
|
| Janus Kinase 2 | 1 | 2017 | 679 | 0.030 |
Why?
|
| Forkhead Box Protein M1 | 1 | 2013 | 113 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2001 | 2022 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 2019 | 1392 | 0.030 |
Why?
|
| Databases, Protein | 1 | 2013 | 100 | 0.030 |
Why?
|
| Quinolines | 1 | 2016 | 383 | 0.030 |
Why?
|
| Schizophrenia | 1 | 2016 | 369 | 0.030 |
Why?
|
| Intestines | 1 | 2017 | 686 | 0.030 |
Why?
|
| Imatinib Mesylate | 1 | 2017 | 1665 | 0.030 |
Why?
|
| PPAR delta | 1 | 2013 | 55 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2013 | 460 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2015 | 974 | 0.030 |
Why?
|
| Protein Kinases | 2 | 2007 | 874 | 0.030 |
Why?
|
| Poly A | 1 | 2012 | 87 | 0.030 |
Why?
|
| Staurosporine | 1 | 2012 | 143 | 0.030 |
Why?
|
| Multigene Family | 1 | 2013 | 425 | 0.030 |
Why?
|
| Histone Acetyltransferases | 1 | 2014 | 411 | 0.030 |
Why?
|
| Pregnancy | 2 | 2002 | 7573 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 2012 | 189 | 0.030 |
Why?
|
| Thiazoles | 1 | 2016 | 726 | 0.030 |
Why?
|
| Silencer Elements, Transcriptional | 1 | 2011 | 6 | 0.030 |
Why?
|
| Neurons | 1 | 2002 | 2287 | 0.030 |
Why?
|
| Insulator Elements | 1 | 2011 | 7 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2013 | 365 | 0.030 |
Why?
|
| Transfection | 1 | 2016 | 2944 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2013 | 566 | 0.020 |
Why?
|
| RNA, Helminth | 1 | 2010 | 7 | 0.020 |
Why?
|
| Genes, Helminth | 1 | 2010 | 25 | 0.020 |
Why?
|
| DNA, Intergenic | 1 | 2010 | 22 | 0.020 |
Why?
|
| Imidazoles | 1 | 2017 | 999 | 0.020 |
Why?
|
| Gene Library | 2 | 2001 | 294 | 0.020 |
Why?
|
| Carcinogenesis | 1 | 2017 | 1026 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3821 | 0.020 |
Why?
|
| Insulin | 1 | 2017 | 1454 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 1084 | 0.020 |
Why?
|
| Piperidines | 1 | 2016 | 1035 | 0.020 |
Why?
|
| Integrin beta1 | 1 | 2011 | 126 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 1547 | 0.020 |
Why?
|
| Stem Cells | 1 | 2017 | 1213 | 0.020 |
Why?
|
| RNA Polymerase II | 1 | 2010 | 182 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 4143 | 0.020 |
Why?
|
| Middle Aged | 4 | 2019 | 86204 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2020 | 5710 | 0.020 |
Why?
|
| Electron Transport | 1 | 2009 | 79 | 0.020 |
Why?
|
| Citric Acid Cycle | 1 | 2009 | 86 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 2015 | 878 | 0.020 |
Why?
|
| RNA, Ribosomal | 1 | 2009 | 83 | 0.020 |
Why?
|
| Ribosomal Proteins | 1 | 2009 | 118 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2015 | 973 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2017 | 1664 | 0.020 |
Why?
|
| In Situ Hybridization | 2 | 2001 | 1037 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2010 | 290 | 0.020 |
Why?
|
| Embryo Implantation | 1 | 2011 | 278 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2011 | 287 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2014 | 992 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2013 | 2316 | 0.020 |
Why?
|
| Oxidative Phosphorylation | 1 | 2009 | 253 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2010 | 602 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2010 | 421 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2010 | 481 | 0.020 |
Why?
|
| Zebrafish Proteins | 1 | 2009 | 163 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2009 | 369 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2010 | 1008 | 0.020 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2007 | 129 | 0.020 |
Why?
|
| Cell Division | 1 | 2011 | 2489 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2007 | 358 | 0.020 |
Why?
|
| Cell Survival | 1 | 2013 | 3045 | 0.020 |
Why?
|
| Kinetics | 1 | 2009 | 2049 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2010 | 785 | 0.020 |
Why?
|
| Temperature | 1 | 2007 | 506 | 0.020 |
Why?
|
| Vitamin K 3 | 1 | 2005 | 6 | 0.020 |
Why?
|
| Sirtuin 2 | 1 | 2005 | 19 | 0.020 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2005 | 33 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 1077 | 0.020 |
Why?
|
| Adenylyl Cyclases | 1 | 2005 | 87 | 0.020 |
Why?
|
| Genotype | 1 | 2013 | 4109 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 8865 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 4938 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2017 | 2027 | 0.020 |
Why?
|
| Aging | 1 | 2013 | 1582 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2005 | 281 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 4757 | 0.020 |
Why?
|
| Age Factors | 1 | 2013 | 5377 | 0.010 |
Why?
|
| Ethanol | 1 | 2005 | 264 | 0.010 |
Why?
|
| Receptors for Activated C Kinase | 1 | 2002 | 7 | 0.010 |
Why?
|
| Spermatids | 1 | 2001 | 42 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2002 | 189 | 0.010 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2002 | 80 | 0.010 |
Why?
|
| ErbB Receptors | 1 | 2010 | 2295 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2001 | 336 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2001 | 682 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2005 | 1442 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 4557 | 0.010 |
Why?
|
| Dogs | 1 | 2001 | 1155 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2001 | 254 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2001 | 272 | 0.010 |
Why?
|
| Phylogeny | 1 | 2001 | 826 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2001 | 545 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2002 | 1618 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2001 | 641 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 2927 | 0.010 |
Why?
|
| Prostate | 1 | 2001 | 1088 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2002 | 1439 | 0.010 |
Why?
|
| Myocardium | 1 | 2001 | 1313 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 21445 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 29902 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 31252 | 0.010 |
Why?
|
| Rats | 1 | 2001 | 6086 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2001 | 5767 | 0.000 |
Why?
|